Certified by Founder Lodge
CTI Life Sciences Fund
Canada - Montreal, Quebec
INVESTOR
1 Disclosed Funding Rounds $80,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to
| Company | Date | Round | Raised |
|---|---|---|---|
 DalCor Pharmaceuticals |
September, 22 ,2023 | Series D | $80,000,000 |
 Glycomine Inc. |
April, 17 ,2025 | Series C | $115,000,000 |
 Aeovian Pharmaceuticals |
December, 17 ,2025 | Unknown | $55,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
